Although current methodology for human health risk assessment assumes
additive interactions among the contaminants of a complex mixture, che
mical interactions may occur which produce synergistic or antagonistic
effects. In this study, the mutagenic response of three model compoun
ds, benzo(a)pyrene (B(a)P), pentachlorophenol (PCP) and 2,4,6-trinitro
toluene (TNT), were tested individually and in binary and tertiary sol
utions, using the Salmonella/microsome assay with each of three bacter
ial tester strains (TA97a, TA98, and TA100). For all strains, B(a)P wa
s mutagenic with metabolic activation (Arochlor 1254-induced Sprague-D
awley rat liver S9 fraction), TNT was mutagenic without metabolic acti
vation, and pentachlorophenol was inactive both with and without metab
olic activation. In binary and tertiary solutions, pentachlorophenol h
ad no effect on the mutagenicity of B(a)P or TNT, independent of metab
olic activation. For strain TA97a, the mutagenicity of B(a)P with meta
bolic activation was slightly decreased in the presence of TNT; the mu
tagenicity of TNT without metabolic activation was slightly decreased
in the presence of B(a)P and PCP; and the mutagenicity of the tertiary
solution (496 revertants/10 ug) with metabolic activation was lower t
han the mutagenicity of B(a)P alone (729 revertants/10 ug). The mutage
nicity of B(a)P in strain TA98 with activation was inhibited by the ad
dition of TNT. Studies conducted using several concentrations of TNT o
r B(a)P indicate that the inhibition of B(a)P mutagenicity was increas
ed as the concentration of TNT increased. Assays performed using four
concentrations of S9 indicated the inhibition of B(a)P mutagenicity wa
s relatively unaffected by the level of S9. The data suggest that an i
nteraction in the presence of TNT limits the concentration of B(a)P th
at is capable of reaching or binding with bacterial DNA. (C) 1998 Else
vier Science Ltd. All rights reserved.